StockData

KALA BIO, Inc. (KALA) stock

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$3.43−0.40 (-10.44%)

Close on Nov 17, 2026Market cap $66.34MP/E –Yield –

Kala Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Kala Bio's price to book ratio was 0.4× on Nov 11, 2026, against 4.2× a year earlier. Over the last 5 years it ranged from 0.4× to 7.7×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−7.3
2025Jul 31, 20257.7×+3.0
2024Dec 31, 20244.7×+3.0
2023Dec 29, 20231.7×−0.9
2022Apr 29, 20222.6×+1.3
2021Dec 31, 20211.3×−2.3
2020Dec 31, 20203.6×+0.6
2019Dec 31, 20193.0×+0.8
2018Dec 31, 20182.2×−2.4
2017Dec 29, 20174.6×–

More Kala Bio figures

See a number that looks wrong?